APA (7th ed.) Citation

FX, R., T, W., H, Z., O, E., J, K., X, Y., . . . B, W. (2024). Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade. Oncoimmunology, 13(1), 2395067. https://doi.org/10.1080/2162402X.2024.2395067

Chicago Style (17th ed.) Citation

FX, Rwandamuriye, et al. "Local Therapy with Combination TLR Agonists Stimulates Systemic Anti-tumor Immunity and Sensitizes Tumors to Immune Checkpoint Blockade." Oncoimmunology 13, no. 1 (2024): 2395067. https://doi.org/10.1080/2162402X.2024.2395067.

MLA (9th ed.) Citation

FX, Rwandamuriye, et al. "Local Therapy with Combination TLR Agonists Stimulates Systemic Anti-tumor Immunity and Sensitizes Tumors to Immune Checkpoint Blockade." Oncoimmunology, vol. 13, no. 1, 2024, p. 2395067, https://doi.org/10.1080/2162402X.2024.2395067.